Akihide Ryo

InstitutionYokohama City University School of Medicine
AddressKanagawa
Japan
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 16 Covid-19 publications, with a maximum of 3 publications in August 2021
    All Publications
    Bar chart showing 143 publications over 20 distinct years, with a maximum of 13 publications in 2017
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Miyakawa K, Jeremiah SS, Kato H, Yamaoka Y, Go H, Yajima S, Shimada T, Mihara T, Goto A, Yamanaka T, Ryo A. Rapid detection of neutralizing antibodies to SARS-CoV-2 variants in post-vaccination sera. J Mol Cell Biol. 2022 01 29; 13(12):918-920. PMID: 34450642.
      Citations: 1     Fields:    
    2. Funabashi R, Miyakawa K, Yamaoka Y, Yoshimura S, Yamane S, Jeremiah SS, Shimizu K, Ozawa H, Kawakami C, Usuku S, Tanaka N, Yamazaki E, Kimura H, Hasegawa H, Ryo A. Development of highly sensitive and rapid antigen detection assay for diagnosis of COVID-19 utilizing optical waveguide immunosensor. J Mol Cell Biol. 2021 12 30; 13(10):763-766. PMID: 34165565.
      Citations:    Fields:    Translation:Humans
    3. Morita T, Miyakawa K, Jeremiah SS, Yamaoka Y, Sada M, Kuniyoshi T, Yang J, Kimura H, Ryo A. All-Trans Retinoic Acid Exhibits Antiviral Effect against SARS-CoV-2 by Inhibiting 3CLpro Activity. Viruses. 2021 08 23; 13(8). PMID: 34452533.
      Citations: 2     Fields:    Translation:HumansAnimalsCells
    4. Miyake S, Higurashi T, Kato H, Yamaoka Y, Kessoku T, Kato S, Ogawa F, Oi Y, Nakajima A, Yamamoto T, Takeuchi I, Ryo A, Maeda S. Evaluation of a combination protocol of CT-first triage and active telemedicine methods by a selected team tackling COVID-19: An experimental research study. J Infect Public Health. 2021 Sep; 14(9):1212-1217. PMID: 34425358.
      Citations:    Fields:    Translation:Humans
    5. Saji R, Nishii M, Sakai K, Miyakawa K, Yamaoka Y, Ban T, Abe T, Ohyama Y, Nakajima K, Hiromi T, Matsumura R, Suzuki N, Taniguchi H, Otsuka T, Oi Y, Ogawa F, Uchiyama M, Takahashi K, Iwashita M, Kimura Y, Fujii S, Furuya R, Tamura T, Ryo A, Takeuchi I. Combining IL-6 and SARS-CoV-2 RNAaemia-based risk stratification for fatal outcomes of COVID-19. PLoS One. 2021; 16(8):e0256022. PMID: 34379684.
      Citations: 1     Fields:    Translation:Humans
    6. Yamaoka Y, Miyakawa K, Jeremiah SS, Funabashi R, Okudela K, Kikuchi S, Katada J, Wada A, Takei T, Nishi M, Shimizu K, Ozawa H, Usuku S, Kawakami C, Tanaka N, Morita T, Hayashi H, Mitsui H, Suzuki K, Aizawa D, Yoshimura Y, Miyazaki T, Yamazaki E, Suzuki T, Kimura H, Shimizu H, Okabe N, Hasegawa H, Ryo A. Highly specific monoclonal antibodies and epitope identification against SARS-CoV-2 nucleocapsid protein for antigen detection tests. Cell Rep Med. 2021 06 15; 2(6):100311. PMID: 34027498.
      Citations: 3     
    7. Goto A, Go H, Miyakawa K, Yamaoka Y, Ohtake N, Kubo S, Jeremiah SS, Mihara T, Senuki K, Miyazaki T, Ikeda S, Ogura T, Kato H, Matsuba I, Sanno N, Miyakawa M, Ozaki H, Kikuoka M, Ohashi Y, Ryo A, Yamanaka T. Sustained Neutralizing Antibodies 6 Months Following Infection in 376 Japanese COVID-19 Survivors. Front Microbiol. 2021; 12:661187. PMID: 34025615.
      Citations:    
    8. Yamaoka Y, Jeremiah SS, Miyakawa K, Saji R, Nishii M, Takeuchi I, Ryo A. Whole Nucleocapsid Protein of Severe Acute Respiratory Syndrome Coronavirus 2 May Cause False-Positive Results in Serological Assays. Clin Infect Dis. 2021 04 08; 72(7):1291-1292. PMID: 32445559.
      Citations: 18     Fields:    Translation:HumansCells
    9. Miyake S, Ashikari K, Kato S, Takatsu T, Kuwashima H, Kaneko H, Nagai K, Watari I, Sato T, Yamaoka Y, Yamamoto T, Ryo A, Maeda S, Nakajima A, Higurashi T. Severe acute respiratory syndrome coronavirus 2 prevalence in saliva and gastric and intestinal fluid in patients undergoing gastrointestinal endoscopy in coronavirus disease 2019 endemic areas: Prospective cross-sectional study in Japan. Dig Endosc. 2022 Jan; 34(1):96-104. PMID: 33548095.
      Citations: 2     Fields:    Translation:Humans
    10. Sundararaj Stanleyraj J, Sethuraman N, Gupta R, Thiruvoth S, Gupta M, Ryo A. Treating COVID-19: are we missing out the window of opportunity? J Antimicrob Chemother. 2021 01 19; 76(2):283-285. PMID: 33099620.
      Citations: 5     Fields:    Translation:Humans
    11. Kubo S, Ohtake N, Miyakawa K, Jeremiah SS, Yamaoka Y, Murohashi K, Hagiwara E, Mihara T, Goto A, Yamazaki E, Ogura T, Kaneko T, Yamanaka T, Ryo A. Development of an Automated Chemiluminescence Assay System for Quantitative Measurement of Multiple Anti-SARS-CoV-2 Antibodies. Front Microbiol. 2020; 11:628281. PMID: 33519790.
      Citations: 4     
    12. Miyakawa K, Jeremiah SS, Ohtake N, Matsunaga S, Yamaoka Y, Nishi M, Morita T, Saji R, Nishii M, Kimura H, Hasegawa H, Takeuchi I, Ryo A. Rapid quantitative screening assay for SARS-CoV-2 neutralizing antibodies using HiBiT-tagged virus-like particles. J Mol Cell Biol. 2020 11 25; 12(12):987-990. PMID: 32931563.
      Citations: 4     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    13. Sada M, Saraya T, Ishii H, Okayama K, Hayashi Y, Tsugawa T, Nishina A, Murakami K, Kuroda M, Ryo A, Kimura H. Detailed Molecular Interactions of Favipiravir with SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza Virus Polymerases In Silico. Microorganisms. 2020 Oct 20; 8(10). PMID: 33092045.
      Citations: 7     
    14. Jeremiah SS, Miyakawa K, Morita T, Yamaoka Y, Ryo A. Potent antiviral effect of silver nanoparticles on SARS-CoV-2. Biochem Biophys Res Commun. 2020 11 26; 533(1):195-200. PMID: 32958250.
      Citations: 44     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    15. Kimura H, Kurusu H, Sada M, Kurai D, Murakami K, Kamitani W, Tomita H, Katayama K, Ryo A. Molecular pharmacology of ciclesonide against SARS-CoV-2. J Allergy Clin Immunol. 2020 08; 146(2):330-331. PMID: 32593491.
      Citations: 11     Fields:    Translation:HumansCellsPHPublic Health
    16. Sethuraman N, Jeremiah SS, Ryo A. Interpreting Diagnostic Tests for SARS-CoV-2. JAMA. 2020 Jun 09; 323(22):2249-2251. PMID: 32374370.
      Citations: 465     Fields:    Translation:HumansCellsPHPublic Health
    17. Yamaoka Y, Matsuyama S, Fukushi S, Matsunaga S, Matsushima Y, Kuroyama H, Kimura H, Takeda M, Chimuro T, Ryo A. Development of Monoclonal Antibody and Diagnostic Test for Middle East Respiratory Syndrome Coronavirus Using Cell-Free Synthesized Nucleocapsid Antigen. Front Microbiol. 2016; 7:509. PMID: 27148198.
      Citations: 16     
    Ryo's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (290)
    Explore
    _
    Co-Authors (121)
    Explore
    _
    Similar People (60)
    Explore
    _